English
Polski
Español
українська
Management of Raynaud phenomenon if calcium channel blocker treatment has failed
What management should be considered in patients with Raynaud phenomenon if treatment with calcium channel blockers has been ineffective?
2024-01-16
What management should be considered in patients with Raynaud phenomenon if treatment with calcium channel blockers has been ineffective?
When to introduce pharmacotherapy in patients with Raynaud phenomenon?
Should we perform capillaroscopy in every patient with Raynaud phenomenon?
What is the risk of a systemic connective tissue disease in persons with Raynaud phenomenon? Does the prognostic value of Raynaud phenomenon differ between women and men?
Should febuxostat be contraindicated in patients with cardiovascular disease? Can it be used as the drug of choice (instead of allopurinol) in long-term gout treatment?
What manifestations of giant cell arteritis are associated with a high risk of vision loss?
Should we treat hyperuricemia without clinically relevant gout?
How does the treatment of primary Raynaud phenomenon differ from that in Raynaud phenomenon secondary, for example, to systemic sclerosis?
What to pay attention to in patients with Raynaud phenomenon? Which diagnostic tests should be routinely performed?
What disorders other than connective tissue diseases can be the cause of Raynaud phenomenon?
